- Home
- VVPR vs SER Comparison
VVPR vs SER Comparison
Compare VVPR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- SER
- Stock Information
- Founded
- VVPR 2014
- SER 2017
- Country
- VVPR United Kingdom
- SER United States
- Employees
- VVPR N/A
- SER N/A
- Industry
- VVPR Power Generation
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- SER Health Care
- Exchange
- VVPR Nasdaq
- SER Nasdaq
- Market Cap
- VVPR 40.2M
- SER 42.0M
- IPO Year
- VVPR 2016
- SER 2018
- Fundamental
- Price
- VVPR $2.45
- SER $3.92
- Analyst Decision
- VVPR
- SER Strong Buy
- Analyst Count
- VVPR 0
- SER 2
- Target Price
- VVPR N/A
- SER $13.00
- AVG Volume (30 Days)
- VVPR 572.0K
- SER 19.5K
- Earning Date
- VVPR 01-01-0001
- SER 11-13-2025
- Dividend Yield
- VVPR N/A
- SER N/A
- EPS Growth
- VVPR N/A
- SER N/A
- EPS
- VVPR N/A
- SER N/A
- Revenue
- VVPR $61,000.00
- SER $116,000.00
- Revenue This Year
- VVPR N/A
- SER $134.46
- Revenue Next Year
- VVPR N/A
- SER N/A
- P/E Ratio
- VVPR N/A
- SER N/A
- Revenue Growth
- VVPR 281.25
- SER N/A
- 52 Week Low
- VVPR $0.62
- SER $3.70
- 52 Week High
- VVPR $8.88
- SER $7.92
- Technical
- Relative Strength Index (RSI)
- VVPR 37.23
- SER 40.00
- Support Level
- VVPR $2.05
- SER $3.68
- Resistance Level
- VVPR $3.64
- SER $4.12
- Average True Range (ATR)
- VVPR 0.35
- SER 0.30
- MACD
- VVPR -0.03
- SER 0.00
- Stochastic Oscillator
- VVPR 27.04
- SER 28.65
About VVPR VivoPower International PLC
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.